Commentary: metformin use is associated with reduced gastric cancer risk
Aliment Pharmacol Ther
.
2014 May;39(10):1239.
doi: 10.1111/apt.12723.
Authors
A C de Vries
1
,
E J Kuipers
Affiliation
1
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. a.c.devries@erasmusmc.nl.
PMID:
24735141
DOI:
10.1111/apt.12723
No abstract available
Publication types
Comment
MeSH terms
Diabetes Mellitus, Type 2 / drug therapy*
Female
Humans
Hypoglycemic Agents / therapeutic use*
Male
Metformin / therapeutic use*
Stomach Neoplasms / prevention & control*
Substances
Hypoglycemic Agents
Metformin